External validation of a prediction model of survival after cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC).

被引:0
|
作者
Bex, Axel
van Werkhoven, Erik D.
Noe, Allard
Karam, Jose A.
Matin, Surena F.
Margulis, Vitaly
Stewart, Grant
Staehler, Michael D.
Wood, Christopher G.
机构
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Amsterdam, Netherlands
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[5] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[6] Univ Munich, Dept Urol, Univ Hosp Munich Grosshadern, Munich, Germany
关键词
D O I
10.1200/jco.2016.34.2_suppl.556
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
556
引用
收藏
页数:1
相关论文
共 50 条
  • [21] The comparison of cytoreductive nephrectomy (CN) with tyrosine kinase inhibitor therapy alone in patients with primary metastatic renal cell carcinoma (mRCC).
    Hatakeyama, Shingo
    Naito, Sei
    Numakura, Kazuyuki
    Kato, Renpei
    Koguchi, Tomoyuki
    Kojima, Takahiro
    Kawasaki, Yoshihide
    Kandori, Kandori
    Tsushima, Eiki
    Nishiyama, Hiroyuki
    Ito, Akihiro
    Kojima, Yoshiyuki
    Habuchi, Tomonori
    Obara, Wataru
    Tsuchiya, Norihiko
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [22] CABOPRE: Phase II study of cabozantinib prior to cytoreductive nephrectomy (CN) in locally advanced and/or metastatic renal cell carcinoma (mRCC).
    de Velasco, Guillermo
    Gonzalez, Borja
    Alonso, Teresa
    Pinto, Alvaro
    Francisco Rodriguez-Moreno, Juan
    Manuel Sepulveda, Juan
    Carlos Villa, Jose
    Miranda, Natalia
    Guerrero, Felix
    Castellano, Daniel E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Mattigk, Angelika
    Zengerling, Friedemann
    UROLOGIE, 2024, 63 (11): : 1151 - 1154
  • [24] Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Chery, Lisly J.
    Karam, Jose A.
    Wood, Christopher G.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (09) : 696 - 703
  • [25] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Healy, Kelly A.
    Marshall, Fray F.
    Ogan, Kenneth
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (08) : 1295 - 1304
  • [26] Cytoreductive nephrectomy for metastatic renal cell carcinoma
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2023, 54 (04) : 270 - 271
  • [27] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Margulis, Vitaly
    Matin, Surena F.
    Wood, Christopher G.
    CURRENT OPINION IN UROLOGY, 2008, 18 (05) : 474 - 480
  • [28] PROGRESSION-FREE AND OVERALL SURVIVAL OF PATIENTS TREATED WITH PRESURGICAL SUNITINIB PRIOR TO CYTOREDUCTIVE NEPHRECTOMY (CN) IN CLEAR CELL SYNCHRONOUS METASTATIC RENAL CELL CARCINOMA (MRCC)
    Bex, Axel
    Blank, Christian
    Chowdhury, Simon
    Nichol, David
    Peters, John
    Horenblas, Simon
    O'Brien, Tim
    Sarwar, Naveed
    Haanen, John
    Powles, Thomas
    JOURNAL OF UROLOGY, 2011, 185 (04) : E709 - E710
  • [29] A MULTICENTER ASSESSMENT OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) WHO RECEIVED IMMUNE CHECKPOINT INHIBITOR THERAPY (ICI) WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY (CN)
    Gross, Evan
    Li, Mingjia
    Yin, Ming
    Orcutt, Delaney
    Hussey, Duncan
    Trott, Elliot
    Kramer, Joel
    Oliva, Kaylee
    Gore, John
    Schade, George
    Lin, Daniel
    Tykodi, Scott
    Hall, Evan
    Thompson, John
    Parikh, Anish
    Yang, Yuanquan
    Collier, Katharine
    Miah, Abdul
    Mori-Vogt, Sherry
    Hinkley, Megan
    Mortazavi, Amir
    Monk, Paul
    Folefac, Edmund
    Clinton, Steven
    Psutka, Sarah
    JOURNAL OF UROLOGY, 2021, 206 : E255 - E255
  • [30] RISK CLASSIFICATION TO PREDICT SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Shinohara, Nobuo
    Abe, Takashige
    Maruyama, Satoru
    Sazawa, Ataru
    Nonomura, Katsuya
    JOURNAL OF UROLOGY, 2012, 187 (04) : E723 - E723